Interactions with prescribers
At GSK we are proud of the work we do in order to fulfil our mission of enabling people to do more, feel better and live longer. We are equally passionate about how we do that work. It is important to all of us at GSK to behave at the highest ethical standards and according to our values: transparency, respect for people, patient-focus and integrity.
Modernising how we work with healthcare professionals
Responding to the needs of patients and meeting the wider expectations of society, at the end of 2013 we initiated a two-year process that will change how we work with healthcare professionals (HCPs) – becoming the first in the sector to move towards ending the practice of paying doctors to speak about our products to other prescribers, and providing financial support to attend medical conferences only through independent third parties.
The UK part of GSK, GSK UK Pharmaceuticals, is making no new arrangements to pay HCPs to speak to other prescribers on our behalf after 1 July 2015.
Recognising our important role in supporting HCPs’ education and in providing accurate information about our medicines to help them make the best treatment decision for their patients, we will strengthen our dedicated medical and scientific capability to appropriately engage with HCPs and improve our multi-channel capabilities, including use of digital technologies, to provide appropriate information on products and disease areas conveniently to HCPs. We will also support fair, balanced and objective medical education for HCPs that delivers measurable patient benefit through provision of independent educational grants.
Find out more about our arm’s-length support of independent medical education.
We will continue to offer appropriate fees to HCPs providing services for GSK-sponsored clinical research, advisory activities and market research. These activities are essential to provide GSK with insights on specific diseases, identification of symptoms and diagnosis, application of clinical trial data or medication dosage and administration and on how to effectively and appropriately communicate the benefits and risks of its medicines to help meet patient needs.
These changes are designed to modernise our relationship with healthcare professionals and bring greater clarity and confidence that whenever we talk to a doctor, nurse or other prescriber, it is patients’ interests that always come first. We understand that while we have an important role to play in providing doctors with information about our medicines, we are expected to do so clearly, transparently and without any perception of conflict of interest.
Patient focus at the heart of our sales and marketing practices
GSK’s sales professionals who work directly with prescribing healthcare professionals are now evaluated and rewarded for their technical knowledge, the quality of the service they deliver to support improved patient care and the overall performance of GSK’s business.
Date of preparation: June 2015 UK/COM/0088/15a